Work

A Review on Cubosomes for Targeted Therapy in Triple-negative Breast Cancer and Optimizing Through Qbd

Year: 2026

Type: article

Abstract: Triple-Negative Breast Cancer, commonly abbreviated as TNBC, is a distinctive form of breast cancer that lacks three critical receptors: estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) as shown in Fig 1. These receptors are typically involved in the growth and spread of most breast cancers, and their absence in TNBC means that common hormonal and targeted therapies are ineffective. TNBC.[1-3] represents roughly 10% to 20% of all breast cancer diagnoses and is known for its particular aggressiveness and tendency to affect younger women compared to other breast cancer types.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.22159644

Author: Muzahidul Islam Akanda1, Prof. Kumaraswamy Gandla2*

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7204648685

FWCI:

Cites:

Cited by:

Related to: